Concord Competitors
| CCM Stock | USD 3.97 0.07 1.79% |
Concord Medical vs Aditxt Correlation
Very weak diversification
The correlation between Concord Medical Services and ADTX is 0.51 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Concord Medical Services and ADTX in the same portfolio, assuming nothing else is changed.
Moving against Concord Stock
| 0.59 | CLH | Cardinal Health | PairCorr |
| 0.53 | DR | Medical Facilities | PairCorr |
| 0.49 | CAH | Cardinal Health Buyout Trend | PairCorr |
| 0.43 | FLGT | Fulgent Genetics | PairCorr |
| 0.35 | BKD | Brookdale Senior Living | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Concord Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Concord Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Concord Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Concord and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Concord Medical Services does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Concord Stock performing well and Concord Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Concord Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SYRA | 5.40 | 0.81 | 0.09 | (1.79) | 5.90 | 19.66 | 36.75 | |||
| XAGE | 6.20 | (0.76) | 0.00 | (0.20) | 0.00 | 18.60 | 46.80 | |||
| IVF | 10.85 | (0.24) | 0.00 | 0.00 | 0.00 | 17.34 | 218.36 | |||
| SISI | 10.32 | 0.14 | 0.00 | (2.02) | 13.96 | 42.86 | 114.83 | |||
| HEPA | 8.69 | (5.54) | 0.00 | 3.17 | 0.00 | 13.95 | 78.13 | |||
| WORX | 5.51 | (0.71) | 0.00 | (0.41) | 0.00 | 10.00 | 57.56 | |||
| CELU | 3.57 | (0.69) | 0.00 | (0.63) | 0.00 | 9.01 | 26.97 | |||
| PTPI | 6.65 | (1.07) | 0.00 | (0.46) | 0.00 | 15.79 | 55.00 | |||
| BACK | 16.39 | 3.52 | 0.19 | (1.26) | 13.94 | 37.80 | 271.43 | |||
| ADTX | 10.03 | (2.67) | 0.00 | (2.76) | 0.00 | 22.54 | 63.67 |
Cross Equities Net Income Analysis
Compare Concord Medical Services and related stocks such as Syra Health Corp, Longevity Health Holdings, and INVO Fertility Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRA | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (3.3 K) | (2.1 M) | (2.9 M) | (3.8 M) | (3.4 M) | (3.2 M) |
| XAGE | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (6.5 M) | (9.1 M) | (15.4 M) | (10.4 M) | (9.3 M) | (9.8 M) |
| IVF | (7.4 K) | (797.5 K) | (666.5 K) | (760.7 K) | (1.7 M) | (5 M) | (2.1 M) | (702.2 K) | (3.1 M) | (2.2 M) | (8.3 M) | (6.7 M) | (10.9 M) | (8 M) | (9.1 M) | (8.2 M) | (7.8 M) |
| SISI | 495.2 K | 5.8 M | 5.8 M | 7.8 M | 7.3 M | 8.1 M | 8.5 M | 7.6 M | 796.2 K | (6.6 M) | (31.4 M) | (24.6 M) | (13.4 M) | (22.4 M) | (22.4 M) | (20.2 M) | (19.2 M) |
| WORX | (386.5 K) | (386.5 K) | (386.5 K) | (386.5 K) | (386.5 K) | (386.5 K) | (4.2 M) | (12 M) | (14.6 M) | (11.5 M) | (7.4 M) | (3.8 M) | (1.8 M) | (4 M) | (1.1 M) | (1.3 M) | (1.4 M) |
| CELU | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (211.9 M) | (208.2 M) | (100.1 M) | 14.2 M | (196.3 M) | (57.9 M) | (66.6 M) | (69.9 M) |
| ADTX | (213 K) | (213 K) | (213 K) | (213 K) | (213 K) | (213 K) | (213 K) | (213 K) | (5.7 M) | (5.8 M) | (9.1 M) | (46.4 M) | (27.6 M) | (32.4 M) | (34.4 M) | (31 M) | (32.6 M) |
Concord Medical Services and related stocks such as Syra Health Corp, Longevity Health Holdings, and INVO Fertility Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Concord Medical Services financial statement analysis. It represents the amount of money remaining after all of Concord Medical Services operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Concord Medical Competitive Analysis
The better you understand Concord Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Concord Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Concord Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Concord Medical Competition Performance Charts
Five steps to successful analysis of Concord Medical Competition
Concord Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Concord Medical Services in relation to its competition. Concord Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Concord Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Concord Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Concord Medical Services, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Concord Medical position
In addition to having Concord Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Farming Thematic Idea Now
Farming
Companies producing farming products and providing services for farmers. The Farming theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Concord Medical Correlation with its peers. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.50) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.